Huaren Health Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2001

Location

Hefei Anhui China

Primary Industry

Retail

About

Established in 2001 and based in Hefei, China, Huaren Health operates as a pharmaceutical manufacturer and distributor that focuses on the pharmaceutical and health industry. The company has about 6000 employees and many strategic partners, such as Shanghai Pharmaceuticals Holding Co.,Ltd., Cisen Pharmaceutical CO.,LTD. and Shandong Zibo Xinda Pharmaceutical Co.,Ltd., etc. In 2019, it established Huida Pharmaceuticals to expand the pharmaceutical retail ecological platform. In January 2023, the company was listed on the Shenzhen stock exchange and its stock code is 301408. The business of the company includes pharmaceutical retail, pharmaceutical agency and terminal collection. The company has pharmaceutical retail platform, supply chain integration platform, management output platform, information technology platform, drug development and innovation platform, medical health services platform and medical devices platform. Its products are divided into four parts, which include brand division, zhengyuan division, guojin division and kuangshu division. Brand division includes oral and pharyngeal category, tonic health category, bruises and bone disease category, etc. Guojin division includes pediatric anthelmintic, tonic, respiratory, purgative and detoxification, such as albendazole chewable tablets and zinc gluconate oral solution.

Current Investors

Huatai Securities

Request a demo to show more

Primary Industry

Retail

Sub Industries

Drug Stores/Convenience Stores, Medical Devices & Equipment, Pharmaceutical Research & Development

Website

www.hrjkjt.com

Verticals

IoT (Internet of Things), Manufacturing

Company Stage

Series A

Total Amount Raised

Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin

31 Dec 2019

1,522,362,891

76,749,920

1,522,362,900

100%

53,347,004

3.5%

31 Dec 2020

31 Dec 2021

31 Dec 2022

Unlock the recent years of financials and more for Huaren Health.

Request a demo to see more.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.